SEC Form 4 · accession 0000899243-16-019805
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin J Driscoll
Officer — President and CEO · Director
Period of report
May 11, 2016
Accepted (ET)
May 12, 2016 · 6:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2016 | P | 12,500 | $12.00 | A | 12,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reports the purchase of shares in the underwritten public offering of common stock of Spring Bank Pharmaceuticals, Inc.